News

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
If an algorithm could help you predict your risk of chronic illness and reveal your likely lifespan, would you want to know? A team of researchers at Duke University, Harvard University, and the ...
An experimental method, which can predict the aging rate of both brain and body, may detect who should implement lifestyle ...
Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...
With dementia diagnoses climbing to 55 million cases globally and 10 million new patients identified each year, medical ...
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...
Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...